Back to today’s briefing

Story perspectives

Texas Invests $50 Million in Psychedelic Addiction Trials

6/10/2025

41 4

Left

Texas Funds Psychedelic Trials

Texas is poised to allocate $50 million for groundbreaking clinical trials of ibogaine, a psychedelic extract, targeting addiction and mental health challenges. Advocates hope this bold move will pave the way for federal approval, offering renewed hope for veterans battling PTSD. The initiative seeks to foster evidence-based reforms in the face of ongoing discussions about the safety and effectiveness of psychedelics.

Right

Trump Explores Psychedelics

The Trump administration is delving into the potential of psychedelics like MDMA and psilocybin to combat PTSD and mental health challenges, especially among veterans. Early clinical trials reveal encouraging outcomes, with MDMA showing promise for PTSD and psilocybin helping with severe depression. Experts urge thorough research and regulation to ensure safe usage.

1 of 2

Texas Funds Psychedelic Trials

Texas is poised to allocate $50 million for groundbreaking clinical trials of ibogaine, a psychedelic extract, targeting addiction and mental health challenges. Advocates hope this bold move will pave the way for federal approval, offering renewed hope for veterans battling PTSD. The initiative seeks to foster evidence-based reforms in the face of ongoing discussions about the safety and effectiveness of psychedelics.

1 / 2